Extracellular Vesicle–Associated miR-ERIA Exerts the Antiangiogenic Effect of Macrophages in Diabetic Wound Healing
Extrazellulärvesikel-assoziiertes miR-ERIA vermittelt den antiangiogenen Effekt von Makrophagen bei der Wundheilung bei Diabetes
Diabetes · 01.04.2025 · 74 (4) · 596-610
DOI: 10.2337/db24-0701 ↗Auf einen Blick
Makrophagen-Extrazellulärvesikel nach AGE-Behandlung hemmten Migration und Tubusbildung von HUVECs. miR-ERIA war daran beteiligt und förderte in vivo die Wundheilung nach Hemmung.
Fragestellung
Wie beeinflussen Makrophagen die Angiogenese und Wundheilung bei diabetischen Hautwunden, und welcher Mechanismus ist beteiligt?
Methode
Experimentelle Zell- und In-vivo-Studie zu Makrophagen-HUVEC-Interaktionen bei Diabetes; Analyse von Extrazellulärvesikeln und miR-ERIA.
Ergebnisse
M1-polarisierte Makrophagen hemmten Migration und Tubusbildung von HUVECs über sekretierte Extrazellulärvesikel nach AGEs-Behandlung. miR-ERIA zielte auf HELZ2; seine Hemmung förderte die Wundangiogenese und beschleunigte die Heilung.
Schlussfolgerung der Autor:innen
miR-ERIA reguliert die diabetische Wundangiogenese über HELZ2 und stellt ein potenzielles therapeutisches Ziel für diabetische Fußulzera dar.
Kernaussagen
- AGEs-EVs aus Makrophagen hemmen HUVEC-Migration und -Tubusbildung
- miR-ERIA zielt auf HELZ2
- miR-ERIA-Hemmung förderte in vivo die Wundangiogenese
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, online erschienen am 24.01.2025. Verfasst von Tingting Zeng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Extracellular Vesicles, Wound Healing, MicroRNAs, Macrophages. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: The National Natural Science Foundation of China Excellent Young Scientists Fund, Ministry of Education, China; Guangzhou Science and Technology Program, Guangdong Clinical Research Center for Metabolic Diseases.
Themen: Wundversorgung
Abstract (Originalsprache)
Many cell types are involved in the regulation of cutaneous wound healing in diabetes. Clarifying the mechanism of cell-cell interactions is important for identifying therapeutic targets for diabetic cutaneous ulcers. The function of vascular endothelial cells in the cutaneous microenvironment is critical, and a decrease in their biological function leads directly to refractory wound healing. In this study, we aimed to examine the interactions of macrophages with vascular endothelial cells and elucidate the mechanism of diabetic wound angiogenesis suppression. We found that macrophages polarized to the M1 type inhibited the migration and tube formation of human umbilical vein endothelial cells (HUVECs) by secreting extracellular vesicles after treatment with advanced glycation end products (AGEs-EVs) and contributed to wound angiogenesis and delayed wound healing in vivo. Mechanistically, we identified a novel miRNA enriched in AGEs-EVs, namely miR-ERIA, that suppresses the biological function of HUVECs by targeting helicase with zinc finger 2 (HELZ2), and in vivo experiments showed that miR-ERIA suppression could promote wound angiogenesis and thus accelerate wound healing in diabetes. We found that miR-ERIA regulates diabetic wound angiogenesis by targeting HELZ2, suggesting a potential therapeutic target for diabetic foot ulcers. Article Highlights An understanding of cell interactions is needed to identify therapeutic targets for diabetic cutaneous ulcers. We explored extracellular vesicles after treatment with advanced glycation end products (AGEs-EVs) derived from macrophages that can suppress diabetic cutaneous wound healing. We found that a novel miRNA enriched in AGEs-EVs (miR-ERIA) suppresses the migration and tube formation of vascular endothelial cells by targeting helicase with zinc finger 2. miR-ERIA offers a potential therapeutic target for diabetic cutaneous ulcers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
- Guangdong Clinical Research Center for Metabolic Diseases, Guangzhou, China.
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen Universi…
- Medical Research Center of Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
- Nanhai Translational Innovation Center of Precision Immunology, Sun Yat-sen Memorial Hospital, Foshan, China.
ORCID-Profile: Tingting Zeng, Li Yan
Förderung
- The National Natural Science Foundation of China Excellent Young Scientists Fund
- Ministry of Education, China; Guangzhou Science and Technology Program
- Guangdong Clinical Research Center for Metabolic Diseases
- Guangzhou Key Laboratory for Metabolic Diseases
- The National Natural Science Foundation of China
- Key Laboratory of Human Microbiome and Chronic Diseases
- National Natural Science Foundation of China
Zitieren
APA
Zeng, T., Sun, K., Mai, L., Hong, X., He, X., Lin, W., Chen, S., & Yan, L. (2025). Extracellular Vesicle–Associated miR-ERIA Exerts the Antiangiogenic Effect of Macrophages in Diabetic Wound Healing. Diabetes, 74(4), 596-610. https://doi.org/10.2337/db24-0701
Vancouver
Zeng T, Sun K, Mai L, Hong X, He X, Lin W, et al. Extracellular Vesicle–Associated miR-ERIA Exerts the Antiangiogenic Effect of Macrophages in Diabetic Wound Healing. Diabetes. 2025;74(4):596-610. doi:10.2337/db24-0701
BibTeX
@article{Zeng2025,
author = {Zeng, Tingting and Sun, Kan and Mai, Lifang and Hong, Xiaosi and He, Xiaodan and Lin, Weijie and Chen, Sifan and Yan, Li},
title = {Extracellular Vesicle–Associated miR-ERIA Exerts the Antiangiogenic Effect of Macrophages in Diabetic Wound Healing},
journal = {Diabetes},
year = {2025},
volume = {74},
number = {4},
pages = {596--610},
doi = {10.2337/db24-0701}
}
EUVIMED